CUSIP: 07160F107
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,576,099
-
Share change
-
+2,011,022
-
Total reported value
-
$16,304,000
-
Price per share
-
$2.48
-
Number of holders
-
48
-
Value change
-
+$1,379,598
-
Number of buys
-
24
-
Number of sells
-
31
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 07160F107:
Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q1 2020
As of 31 Mar 2020,
BAUDAX BIO INC - COM (BXRX) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,576,099 shares.
The largest 10 holders included
NORTH RUN CAPITAL, LP, CORSAIR CAPITAL MANAGEMENT, L.P., Stonepine Capital Management, LLC, BlackRock Inc., CVI Holdings, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., SABBY MANAGEMENT, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and Brandywine Global Investment Management, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.